Yüklüyor......

Vaccines for the prevention against the threat of MERS-CoV

First identified in 2012, Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) is listed as a new Category C Priority Pathogen. While the high mortality of MERS-CoV infection is further intensified by potential human-to-human transmissibility, no MERS vaccines are available for human use....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Expert Rev Vaccines
Asıl Yazarlar: Du, Lanying, Tai, Wanbo, Zhou, Yusen, Jiang, Shibo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2016
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5097835/
https://ncbi.nlm.nih.gov/pubmed/26985862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14760584.2016.1167603
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!